Arcturus Therapeutics Holdings Inc (ARCT)

Arcturus Therapeutics Holdings Inc (ARCT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $308M; returns 1 day -8.3%, 1 week -4.8%, 1 year -18.0%.

Arcturus Therapeutics Holdings Inc. (ARCT) is a commercial-stage mRNA medicines and vaccines company founded in 2013 and based in San Diego, California. The company leverages its proprietary STARR® mRNA platform and LUNAR® lipid-mediated delivery technology.

Groups ARCT belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Commercial Stage Biotech
• Pharmaceuticals
• Clinical Stage Biopharma
• Life Sciences
• Biologics
• COVID-19
• Cystic Fibrosis Therapies
• Rare Diseases
• Infectious Diseases

ARCT financial model: income statement, cash flow and balance sheet